Idaho Trust Bank’s Pfizer PFE Stock Holding History

Idaho Trust Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,080	Closed	-$235K	–	84
2023 Q3	$235K	Hold	7,080	–	–	0.15%	72
2023 Q2	$260K	Buy	+7,080	New	+$276K	0.16%	70

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Idaho Trust Bank's PFE Position: Q4 2023 in Review

Idaho Trust Bank sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,080 shares — an estimated $235K sold.

Idaho Trust Bank first reported a position in PFE in Q2 2023 and held it in 2 quarters. The position peaked at $260K in Q2 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Idaho Trust Bank reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Idaho Trust Bank sold 7,080 Pfizer shares in Q4 2023, an estimated $235K.
Idaho Trust Bank first reported a position in Pfizer in Q2 2023 and held it in 2 quarters.
Idaho Trust Bank's Pfizer position peaked at $260K in Q2 2023.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Idaho Trust Bank's 13F filing for Q4 2023, filed 6 Feb 2024.